Erratum to: Vedolizumab: A Review of Its Use in Adult Patients with Moderately to Severely Active Ulcerative Colitis or Crohn’s Disease

1 Erratum to: BioDrugs (2014) DOI 10.1007/s40259-014-0113-2

The author has alerted us to the following error:

Table 2, Section 4.2: The cell entry in the ‘Population’ column which previously read:

“TNF-agonist-naïve”

should read:

“TNF-antagonist-naïve”